Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
-
Narrated by:
-
By:
About this listen
Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials?
In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed.
Listen to our latest podcast now for more info!
Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information
What listeners say about Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.